Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.09 | N/A |
| PEG Ratio (TTM) | 1.17 | N/A |
| P/S Ratio (TTM) | 1.56 | N/A |
| P/B Ratio (TTM) | 2.45 | N/A |
| P/FCF Ratio (TTM) | 18.34 | N/A |
| Price to 5YR AVG Earnings Ratio | 30.43 | N/A |
| Price to 5YR AVG FCF Ratio | 30.20 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.19% | N/A |
| ROE (TTM) | 12.95% | N/A |
| Net Profit Margin (TTM) | 7.40% | N/A |
| ROIC 5YR AVG | 7.68% | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -50.16% | 32.49% | 21.36% |
| Revenue | 0.88% | 0.38% | 12.79% |
| Net Income | 28.76% | 29.47% | 24.11% |
| Cash Flow | -7.91% | -5.58% | 31.39% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.85 | N/A |
| Quick Ratio (TTM) | 1.32 | N/A |
| D/E Ratio (TTM) | 0.92 | N/A |
| Interest Coverage (TTM) | 2.44 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.70 | N/A |
| LTL to 5YR AVG FCF | 12.17 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.73% | N/A |